BioSpace News Archive

3D illustartion of a B-cell producing and releasing antibodies

Startups

Candid Debuts With $370M, Targets Leadership in T Cell Engager Space

Candid Therapeutics, which is repositioning two antibodies for autoimmune indications, will be led by Ken Song who was previously CEO of RayzeBio and oversaw its $4.1 billion acquisition by Bristol Myers Squibb.

September 10, 2024

·

2 min read

·

Tristan Manalac

Fashionable halftone collage. Concept of wealth, saving, saving and saving money. Money bag with dollar stacks and stacks of coins. Vector illustration of business and finance for web banner, social media banner, marketing material. Vector illustration

Funding

Terns Announces $125M Raise on Heels of Oral GLP-1 Data Drop

Phase I data for TERN-601 suggests Terns’ oral GLP-1 candidate for obesity could be a contender in the market next to big names like Lilly, Pfizer and Roche.

September 10, 2024

·

1 min read

·

Kate Goodwin

Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells 3d rendering

Antibody-drug conjugate (ADC)

AstraZeneca, Daiichi Sankyo’s Dato-DXd Fails to Significantly Improve Overall Survival in Phase III NSCLC

Despite the disappointing late-stage results in non-small cell lung cancer, Jefferies analyst Stephen Barker contends the likelihood of FDA approval “remains high” for the experimental antibody-drug conjugate, though the regulator is now more likely to convene an advisory committee.

September 10, 2024

·

2 min read

·

Tristan Manalac

Trendy halftone collage of business concept. Money making concept. Trendy modern retro illustration. Vector illustration of business, contract approval, finance, marketing materials. Vector illustration

Startups

Roivant Creates New ‘Vant’ to License Bayer’s Pulmonary Hypertension Drug

Under an in-license agreement worth up to $294 million, Roivant Sciences gains exclusive worldwide rights from Bayer to develop and commercialize mosliciguat, a potential first-in-class inhaled soluble guanylate cyclase activator.

September 10, 2024

·

2 min read

·

Tristan Manalac

External view of the U.S. Capitol building

BIOSECURE Act

BIOSECURE Act Sails Through House Passage, Lines Up Senate Vote

The U.S. House of Representatives on Monday overwhelmingly passed the bipartisan bill, which targets WuXi AppTec, WuXi Biologics and other Chinese biotech companies as potential national security risks.

September 10, 2024

·

2 min read

·

Tristan Manalac

Press Releases

Adena Health vascular surgeon’s skill saves patient’s foot

September 10, 2024

·

3 min read

Press Releases

UPDATE - IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management